We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A House bill would place a two-year moratorium on Medicare payment cuts for diagnostic imaging that were included in the 2005 Deficit Reduction Act (DRA) passed by Congress in February.
Baxter Healthcare has signed a consent decree with the FDA related to violations of current good manufacturing practices (cGMPs) in making two brands of infusion pumps, the agency said June 29.
Frost & Sullivan, the leading global growth consulting company has chosen CytoGenix as the recipient of the 2006 Technology Innovation Award in biotechnology processing for the development of the synDNA large-scale DNA production technology.
Noven Pharmaceuticals, Inc. today confirmed that Shire plc has launched Daytrana (methylphenidate transdermal system), the first and only transdermal medication approved to treat the symptoms of Attention Deficit Hyperactivity Disorder (ADHD) in children aged six to twelve years, and that the product is now available in retail pharmacies.
Thursday, InSite Vision, Inc., an ophthalmic products company, revealed the submission of a New Drug Application or NDA with the U.S. Food and Drug Administration for AzaSite indicated in the treatment of bacterial conjunctivitis.
Bayer Diagnostics India Ltd will become a part of the Siemens Group, following the worldwide sale of the Bayer Group's diagnostic business to Simens AG for a price of 4.2 billion Euros.
Integra LifeSciences Holdings Corporation announced today that it has agreed to acquire the shares of Kinetikos Medical, Inc. ("KMI") for approximately $40 million in cash, subject
to certain adjustments, including future payments based on the performance of the KMI business after the acquisition.
Smith & Nephew became the latest orthopedic-products maker on Friday to get a subpoena from the U.S. Department of Justice as an examination over potential violations of antitrust law proceeds.